2017 • Engineering and Technology
Redesigned Bubble CPAP to Effectively Curtail Preterm Infant Mortality in Low Resource Areas
Lead Presenter: Elikem Tettey-Tamaklo
PI: Solomon Mensah, Arthur Coury
Respiratory distress syndrome (RDS) is a lung disorder that affects the normal breathing of preterm infants by preventing their lungs from staying open leading to obstructed breathing. This disorder is responsible for much of the largely preventable preterm infant mortality in many developing countries.
The solution to this disease would be to provide the preterm babies with a constant supply of oxygen until their lungs mature enough to stay open without help. Commercial respiratory assistants are very expensive and made for first world facilities, but are being used in third world hospitals. Their combination of high cost and complexity result in the inability of local hospitals to afford or maintain them when they break. The result is less of these devices available to cater to the growing infant mortality crisis within developing countries.
In an attempt to curb the problem, a cost-effective and practical intervention would be necessary. This intervention comes in the form of a completely redesigned bCPAP. This device is a respiratory device that provides the ideal mixture of oxygen and air, delivered to the delicate lungs of the baby.
Therapeutic Innovations redesigns medical devices towards third world countries by removing unnecessary complex features while still maintaining reliable functionality. Part of our solution is to use pre-fabricated parts from medical suppliers and assembling them in a novel modular fashion to create our bCPAP. This removes manufacturing and approval costs, and allow us to focus on designing our product towards the conditions of third world countries.